CVS Health lifts adjusted income in Q2 as Aetna rebounds, Caremark retention holds CVS Health Corporation reported ...

The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.

CVS’s stock was having its best day in more than five months, amid strong growth in all of the company’s business units.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

CVS Health reported second quarter total revenues increased to $98.9 billion, up 8.4% compared to the prior year period.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...

CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation ...

The company raised its outlook as many insurers are struggling with elevated medical costs in the second quarter.

The injunction is a loss for Gov. Sarah Sanders and a win for CVS, which previously said the state law likely would have ...

A federal judge has temporarily blocked a first-in-the-nation law that would prohibit companies that own PBMs from also ...